Oral compound drug for treating oral ulcer

Abstract

The invention discloses an oral compound drug for treating oral ulcer. The oral compound drug provided by the invention is made from the following components of: by weight, 12 parts of fried Garcinia mangostana, 15 parts of fried tingli seed, 12 parts of fried Plantain seed, 12 parts of calcined gypsum, 12 parts of calcined Borax, 12 parts of calcined calamine, 12 parts of calcined Renzhongbai, 10 parts of dried alum, 9 parts of lime, 12 parts of talcum, 3 parts of borneol, 0.2 part of streptomycin and 0.2 part of erythromycin. The drug for treating oral ulcer has advantages of high cure rate, remarkable effects, drug source easily available, no phytotoxicity and low price. The effective rate reaches 95% and the cure rate reaches 92.5%.

Description

technical field [0001] The invention relates to a medicine for treating oral ulcer, in particular to a compound medicine for oral cavity for treating oral ulcer. Background technique [0002] Oral ulcers include oral diseases such as stomatitis, thrush, herpetic stomatitis, and recurrent stomatitis. Local ulcerative injury disease. Main symptoms: Single or multiple round or oval ulcers of different sizes, such as rice grains or soybeans, occur on the mucous membranes of the lips, cheeks, soft palate or gums of the oral cavity. Clear, the surrounding mucosa is red and slightly swollen, and the ulcer is localized with burning pain. It is cyclical, recurrent, and self-limiting. The etiology may be local trauma, mental stress, food, drugs, changes in hormone levels, and lack of vitamins or trace elements. Systemic diseases, genetics, immunity and microorganisms may play an important role in its occurrence and development. [0003] Motherland medicine believes that oral ulce...

AI Technical Summary

Problems solved by technology

Another example: the application number 03108592x disclosed by the National Patent Office on April 12, 2004, the title of invention "a medicine for the treatment of oral ulcers" is more un